A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Diabetic Peripheral Neuropathic Pain (NP05).
Clinical trial NCT05620576 · COMPLETED
Trial details
- NCT number
- NCT05620576
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-14
- Primary completion
- 2023-07-19
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.